See more : The Monogatari Corporation (3097.T) Income Statement Analysis – Financial Results
Complete financial analysis of Semper Paratus Acquisition Corporation (LGST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Semper Paratus Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
You may be interested
- Eurobank Ergasias Services and Holdings S.A. (EUROB.AT) Income Statement Analysis – Financial Results
- TransDigm Group Incorporated (TDG) Income Statement Analysis – Financial Results
- GN Store Nord A/S (GNNDY) Income Statement Analysis – Financial Results
- Vitamin Blue, Inc. (VTMB) Income Statement Analysis – Financial Results
- Snoogoo Corp. (SGOO) Income Statement Analysis – Financial Results
Semper Paratus Acquisition Corporation (LGST)
About Semper Paratus Acquisition Corporation
Semper Paratus Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the transportation, supply chain, and logistics industries. The company was incorporated in 2021 and is based in New York, New York.
| Metric | 2022 | 2021 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 |
| General & Administrative | 953.08K | 272.13 |
| Selling & Marketing | 0.00 | 181.15K |
| SG&A | 953.08K | 181.42K |
| Other Expenses | 0.00 | 0.00 |
| Operating Expenses | 953.08K | 181.42K |
| Cost & Expenses | 953.08K | 181.42K |
| Interest Income | 0.00 | 15.81K |
| Interest Expense | 0.00 | 0.00 |
| Depreciation & Amortization | 10.72M | 236.56K |
| EBITDA | -6.31M | -181.42K |
| EBITDA Ratio | 0.00% | 0.00% |
| Operating Income | -17.04M | -181.42K |
| Operating Income Ratio | 0.00% | 0.00% |
| Total Other Income/Expenses | 5.36M | 152.68K |
| Income Before Tax | 4.41M | -28.75K |
| Income Before Tax Ratio | 0.00% | 0.00% |
| Income Tax Expense | -10.72M | -16.08K |
| Net Income | 15.13M | -28.75K |
| Net Income Ratio | 0.00% | 0.00% |
| EPS | 0.42 | 0.00 |
| EPS Diluted | 0.42 | 0.00 |
| Weighted Avg Shares Out | 35.95M | 47.93M |
| Weighted Avg Shares Out (Dil) | 35.95M | 47.93M |
Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGN
WARREN, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen Bio”), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virology, oncology, and neurology, has announced the completion of Tevogen Bio Inc's...
Semper Paratus Acquisition Corporation's Shareholders Approve Business Combination with Tevogen Bio
New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company, announced today that its shareholders have approved the proposed business combination (the “Business Combination”) with...
Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq
New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW), a publicly-traded special purpose acquisition company, today announced that it has filed a supplement (“Prospectus Supplement”) to its definitive proxy statement/prospectus dated...
Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination
New York, NY, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Inc (“Tevogen Bio”), an advanced-stage specialty immunotherapy biotech pioneer and Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW), a publicly-traded special purpose acquisition company, today announced that the...
Semper Paratus Acquisition Corporation Regains Compliance with Certain Nasdaq Listing Requirement
New York, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (Nasdaq: LGST, the “ Company ”) announced today that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) confirming that...
Semper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc
New York, NY, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (Nasdaq: LGST) (“Semper Paratus”), a publicly traded special purpose acquisition company, today announced the filing of a registration statement on Form S-4 (the “Registration Statement”) with the...
Citadel Advisors LLC's Recent Transaction in Semper Paratus Acquisition Corp
On July 17, 2023, Citadel Advisors LLC (Trades, Portfolio), a prominent investment firm, executed a transaction involving Semper Paratus Acquisition Corp ( LGSTU , Financial). This article provides an in-depth analysis of the transaction, the profiles of both Citadel Advisors...
Source: https://incomestatements.info
Category: Stock Reports